Corteva, Inc. — Q1 2024 Form 10-Q
Business context and reporting period. This unaudited combined quarterly report covers the three months ended March 31, 2024. Corteva operates through Seed and Crop Protection; the filing also includes EIDP, its wholly owned subsidiary, as a separate reporting company. Unless noted, figures below refer to Corteva and are in U.S. dollars.
Financial results and key metrics
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Net sales | $4.492 billion | $4.884 billion |
| Income from continuing operations after tax | $376 million | $607 million |
| Net income attributable to Corteva | $419 million | $595 million |
| Diluted EPS, total | $0.60 | $0.83 |
| Operating EBITDA (non-GAAP) | $1.034 billion | $1.231 billion |
| Operating earnings per share (non-GAAP) | $0.89 | $1.16 |
| Cash from continuing operating activities | $(2.606) billion | $(3.302) billion |
- Sales fell 8%, reflecting volume down 9% and currency down 2%, partly offset by price up 3%. Cost of goods sold was $2.550 billion, or 57% of sales, versus $2.771 billion, also 57% of sales; implied gross margin was approximately 43% in both periods.
- Seed sales rose 2% to $2.751 billion and segment operating EBITDA increased to $748 million from $652 million; segment EBITDA margin improved about 300 basis points.
- Crop Protection sales declined 20% to $1.741 billion and segment operating EBITDA fell to $310 million from $603 million; margin contracted by more than 970 basis points. Lower volumes, unfavorable mix, price pressure, currency and input costs weighed on results.
- Q1 GAAP net income includes $47 million after-tax income from discontinued operations, compared with an $8 million loss a year earlier. The 2024 benefit primarily reflected favorable adjustments to prior-year tax positions, partly offset by PFAS-related charges.
- Cash and marketable securities were $1.658 billion at March 31, 2024, down from $2.742 billion at year-end 2023. Total debt was $4.640 billion, up from $2.489 billion; the increase primarily funded seasonal working capital, capital spending, dividends and buybacks. Current assets were $17.163 billion and current liabilities $11.332 billion.
- Operating cash use remained seasonal and was partly offset by $1.766 billion of financing cash inflows. Investing cash use was $270 million, including $148 million of capital expenditures. Corteva returned approximately $365 million to shareholders through buybacks and dividends.
Material changes and management commentary
- Management attributed lower overall sales and earnings chiefly to Crop Protection volume declines, destocking and unfavorable weather in EMEA, alongside competitive pricing in North and Latin America. Seed performance improved on pricing, royalty expense and productivity actions.
- Management described the 2024 agricultural outlook as stable, with mostly constructive fundamentals. It expects Crop Protection market growth in the second half of 2024 after significant 2023 destocking. Higher input costs were expected to ease for Crop Protection in that half.
- The company reaffirmed full-year 2024 outlook: net sales of $17.4–$17.7 billion; Operating EBITDA of $3.5–$3.7 billion; operating EPS of $2.70–$2.90; cash from continuing operating activities of $2.1–$2.6 billion; and free cash flow of $1.5–$2.0 billion. The outlook excludes extreme weather, operational disruptions, significant customer-demand or payment changes, and further acceleration in currency or inflation impacts.
- The Crop Protection restructuring program is expected to generate about $100 million of annual run-rate savings by 2025. Expected aggregate pre-tax charges are $410–$460 million; $284 million had been recorded through Q1 2024. Management expects $90–$120 million of future cash payments and substantial completion in 2024. The company expects $180–$230 million of restructuring charges during 2024, plus about $60 million of non-cash accelerated royalty amortization.
- The 2022 restructuring actions are expected to deliver $210–$220 million of annual run-rate savings by 2025; management does not anticipate additional material charges from those actions.
Debt, liquidity, contingencies and risks
- At March 31, the company had $6.0 billion of committed revolving credit available and approximately $6.5 billion of committed and uncommitted unused credit lines in total. It was in compliance with its debt covenants, including the maximum 0.60 total-debt-to-total-capitalization ratio.
- PFAS and other legacy environmental matters remain significant uncertainties. The Nationwide Water District Settlement fund received $1.185 billion collectively from the settling companies in 2023. The court granted final approval in February 2024; the judgment became final in April, after the quarter, releasing restrictions on the fund and resulting in derecognition of the associated liability. Corteva’s specific cash contribution is not clearly stated in the supplied filing text.
- For environmental matters, the filing reports $503 million of accrued obligations and $655 million of potential exposure above accruals; these figures cover specified categories and do not represent a single estimate of total litigation exposure. Management says losses beyond accruals could be material, but it cannot estimate possible losses for certain proceedings.
- Other notable proceedings include FTC and state antitrust litigation, Lorsban-related personal injury claims, patent and licensing disputes, and numerous legacy PFAS matters. Corteva says it intends to defend the FTC case; outcomes and potential losses in several matters remain uncertain. The EPA announced drinking-water limits and designated PFOA and PFAS as hazardous substances in April 2024.
- Other risks identified include regulation and product approvals, weather and climate, competition, input-cost and currency volatility, customer credit, supply-chain and IT disruption, intellectual property, and the company’s legacy indemnification obligations. Management reported no material change to the risk factors in its latest annual report.
Important facts for investors to verify
- Whether Crop Protection demand, destocking, pricing and input-cost trends improve as management expects in the second half of 2024.
- Progress and realized savings from the Crop Protection restructuring, alongside remaining charges and cash payments.
- Seasonal working-capital cash use, receivables and customer financing, and the rise in short-term borrowings and total debt.
- Execution against full-year sales, EBITDA, operating EPS and cash-flow guidance, including the assumptions and exclusions underlying the outlook.
- Developments in PFAS settlements, environmental claims and other litigation, including possible amounts above recorded accruals and the company-specific share of shared settlements.
- Non-GAAP measures are company-defined and exclude certain items; compare them with GAAP results and review the filing’s reconciliations.